CAS No. |
948840-25-3 |
中文名称 |
(E)-1-[5-[(1R,2S,3R)-1,2,3,4-四羟基丁基]-1H-咪唑-2-基]乙烷-1-酮肟 |
英文名称 |
(E)-1-(5-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethan-1-one oxime |
别名 |
LX2931;LX-2931
(LX2931);(1R,2S,3R)-1-[(2E)-2-(1-nitrosoethylidene)-1,3-dihydroimidazol-4-yl]butane-1,2,3,4-tetrol;Ethanone, 1-[5-[(1R,2S,3R)-1,2,3,4-tetrahydroxybutyl]-1H-imidazol-2-yl]-, oxime, (1E)- |
标准英文名 |
(E)-1-(5-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethan-1-one oxime |
分子式 |
C9H15N3O5 |
分子量 |
245.24
|
精确分子量 |
245.10
|
SMILES |
C/C(=N\O)C1=NC=C([C@@H](O)[C@H](O)[C@H](O)CO)N1 |
标准SMILES |
C/C(=N\O)/C1NC(=CN=1)[C@@H](O)[C@H](O)[C@H](O)CO |
用途 |
LX2931 is used in research for the treatment of autoimmune diseases, particularly rheumatoid arthritis, by inhibiting Sphingosine-1-Phosphate Lyase (S1PL), which leads to increased intracellular and extracellular S1P levels, restricts lymphocyte egress from secondary lymphoid tissues, and results in peripheral blood lymphopenia and immunosuppression. |
InChIKey |
AMXVYJYMZLDINS-RSWLNLDNSA-N |